Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Laboratory reactivity testing lacks utility for hypertension evaluation or therapy assessment; leaves open its mechanistic relevance in future studies.
Cardiovascular reactivity has long been measured in laboratory responses to a wide variety of cognitive and physical stressors, with the hypothesis that exaggerated reactivity plays a pathogenetic role in the development of essential hypertension. However there are few data to support the belief that behavioural differences of cognitive perception of stressors account for observed differences of reactivity. Cardiovascular reactivity in the laboratory does not predict hypertension or account for differences of blood pressure variability in the natural environment. Hypertensives do not exhibit increased blood pressure variability. Antihypertensive therapy consistently fails to lower cardiovascular reactivity in either the laboratory or natural milieu, supporting the dual and largely independent regulation of the basal and reactive blood pressures. It is concluded that there is little support for the use of laboratory stress testing to delineate either the pathogenesis of hypertension, the evaluation of hypertensive subjects, or the efficacy of antihypertensive therapy.
No takes yet. Share an insight, caveat, or question.
Rosenman et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: